Using the lymphatics to study nutrient absorption and the secretion of gastrointestinal hormones

Physiology and Behavior

Volumn 105, Issue 1, 2011, Pages 82-88

  Kohan, Alison B ^a   Yoder, Stephanie M ^b   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chylomicron; Glucagon like peptide 1 (GLP 1); Glucose dependent insulinotropic polypeptide (GIP); Incretin; Lymph; Lymph fistula rat model

Indexed keywords

APOLIPOPROTEIN A4; CHYLOMICRON; FATTY ACID; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; INCRETIN; LIPID;

ARTICLE; ENTEROENDOCRINE CELL; EXPERIMENTAL MODEL; FAT INTAKE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; HORMONAL REGULATION; HORMONE ACTION; HORMONE RELEASE; HUMAN; INTESTINE CELL; LIPID ABSORPTION; LIPID TRANSPORT; LYMPH FLOW; LYMPHATIC FISTULA; LYMPHATIC SYSTEM; MACRONUTRIENT; NONHUMAN; NUTRIENT UPTAKE; PRIORITY JOURNAL; PROTEIN SECRETION;

ANIMALS; GASTROINTESTINAL HORMONES; GASTROINTESTINAL TRACT; LIPID METABOLISM; LYMPHATIC SYSTEM;

EID: 80053460336     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.04.056     Document Type: Article

References (91)

1. Bayliss W.M., Starling E.H. The mechanism of pancreatic secretion. J Physiol 1902, 28:325-353.
2. Junqueira L.C., Carneiro J. Basic Histology 2005, McGraw-Hill Co, New York. 11th ed.
3. Granger D.N., Barrowman J.A., Kvietys P.R. Clinical gastrointestinal physiology 1985, W. B. Saunders Co, Philadelphia.
4. Swartz M.A. The physiology of the lymphatic system. Adv Drug Deliv Rev 2001, 50:3-20.
5. Cueni L.N., Detmar M. The lymphatic system in health and disease. Lymphat Res Biol 2008, 6:109-122.
6. Thomson A.B., Keelan M., Garg M.L., Clandinin M.T. Intestinal aspects of lipid absorption: in review. Can J Physiol Pharmacol 1989, 67:179-191.
7. Tso P. Gastrointestinal digestion and absorption of lipid. Adv Lipid Res 1985, 21:143-186.
8. Erlanson-Albertsson C. Pancreatic colipase. Structural and physiological aspects. Biochim Biophys Acta 1992, 1125:1-7.
9. Morgan R.G., Barrowman J., Borgstrom B. The effect of sodium taurodesoxycholate and pH on the gel filtration behavior of rat pancreatic protein and lipases. Biochim Biophys Acta 1969, 175:65-75.
10. Savary P., Constantin M.J., Desnuelle P. On the structure of the triglycerides of the lymphatic chylomicrons in the rat. Biochim Biophys Acta 1961, 48:562-571.
11. Sternby B., Borgstrom B. Purification and characterization of human pancreatic colipase. Biochim Biophys Acta 1979, 572:235-243.
12. Abrams C.K., Hamosh M., Lee T.C., Ansher A.F., Collen M.J., Lewis J.H., et al. Gastric lipase: localization in the human stomach. Gastroenterology 1988, 95:1460-1464.
13. Breckenridge W.C., Marai L., Kuksis A. Triglyceride structure of human milk fat. Can J Biochem 1969, 47:761-769.
14. Borgstrom B. The micellar hypothesis of fat absorption: must it be revisited?. Scand J Gastroenterol 1985, 20:389-394.
15. Hofmann A.F., Borgstroem B. The intraluminal phase of fat digestion in man: the lipid content of the micellar and oil phases of intestinal content obtained during fat digestion and absorption. J Clin Invest 1964, 43:247-257.
16. Hofmann A.F., Borgstrom B. Physico-chemical state of lipids in intestinal content during their digestion and absorption. Fed Proc 1962, 21:43-50.
17. Manganaro F., Kuksis A. Purification and preliminary characterization of 2-monoacylglycerol acyltransferase from rat intestinal villus cells. Can J Biochem Cell Biol 1985, 63:341-347.
18. Rao G.A., Johnston J.M. Purification and properties of triglyceride synthetase from the intestinal mucosa. Biochim Biophys Acta 1966, 125:465-473.
19. Bass N.M. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. Int Rev Cytol 1988, 111:143-184.
20. Glatz J.F., Veerkamp J.H. Intracellular fatty acid-binding proteins. Int J Biochem 1985, 17:13-22.
21. Storch J., McDermott L. Structural and functional analysis of fatty acid-binding proteins. J Lipid Res 2009, 50(Suppl):S126-S131.
22. Tso P., Pitts V., Granger D.N. Role of lymph flow in intestinal chylomicron transport. Am J Physiol 1985, 249:G21-G28.
23. Tso P., Barrowman J.A., Granger D.N. Importance of interstitial matrix hydration in intestinal chylomicron transport. Am J Physiol 1986, 250:G497-G500.
24. Kondoh M., Yagi K. Progress in absorption enhancers based on tight junction. Expert Opin Drug Deliv 2007, 4:275-286.
25. Ilback N.G., Nyblom M., Carlfors J., Fagerlund-Aspenstrom B., Tavelin S., Glynn A.W. Do surface-active lipids in food increase the intestinal permeability to toxic substances and allergenic agents?. Med Hypotheses 2004, 63:724-730.
26. Kvietys P.R., Specian R.D., Grisham M.B., Tso P. Jejunal mucosal injury and restitution: role of hydrolytic products of food digestion. Am J Physiol 1991, 261:G384-G391.
27. Brown J.C., Mutt V., Pederson R.A. Further purification of a polypeptide demonstrating enterogastrone activity. J Physiol 1970, 209:57-64.
28. Schmidt W.E., Siegel E.G., Creutzfeldt W. Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets. Diabetologia 1985, 28:704-707.
29. Getty-Kaushik L., Song D.H., Boylan M.O., Corkey B.E., Wolfe M.M. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity (Silver Spring) 2006, 14:1124-1131.
30. Kim S.J., Winter K., Nian C., Tsuneoka M., Koda Y., McIntosh C.H. Glucose-dependent insulinotropic polypeptide (GIP) stimulation of pancreatic beta-cell survival is dependent upon phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB) signaling, inactivation of the forkhead transcription factor Foxo1, and down-regulation of bax expression. J Biol Chem 2005, 280:22297-22307.
31. Wang Y., Montrose-Rafizadeh C., Adams L., Raygada M., Nadiv O., Egan J.M. GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells. Mol Cell Endocrinol 1996, 116:81-87.
32. Miyawaki K., Yamada Y., Ban N., Ihara Y., Tsukiyama K., Zhou H., et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002, 8:738-742.
33. Althage M.C., Ford E.L., Wang S., Tso P., Polonsky K.S., Wice B.M. Targeted ablation of glucose-dependent insulinotropic polypeptide-producing cells in transgenic mice reduces obesity and insulin resistance induced by a high fat diet. J Biol Chem 2008, 283:18365-18376.
34. Fulurija A., Lutz T.A., Sladko K., Osto M., Wielinga P.Y., Bachmann M.F., et al. Vaccination against GIP for the treatment of obesity. PLoS One 2008, 3:e3163.
35. Deacon C.F. What do we know about the secretion and degradation of incretin hormones?. Regul Pept 2005, 128:117-124.
36. Layer P., Peschel S., Schlesinger T., Goebell H. Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 1990, 258:G196-G201.
37. Maljaars P.W., Peters H.P., Mela D.J., Masclee A.A. Ileal brake: a sensible food target for appetite control. rev Physiol Behav 2008, 95:271-281.
38. Nauck M.A., Niedereichholz U., Ettler R., Holst J.J., Orskov C., Ritzel R., et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997, 273:E981-E988.
39. Spiller R.C., Trotman I.F., Adrian T.E., Bloom S.R., Misiewicz J.J., Silk D.B. Further characterisation of the 'ileal brake' reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 1988, 29:1042-1051.
40. Gutzwiller J.P., Goke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., et al. Glucagon-like peptide-1: a potent regulator of food intake in humans. Gut 1999, 44:81-86.
41. Larsen P.J., Fledelius C., Knudsen L.B., Tang-Christensen M. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats. Diabetes 2001, 50:2530-2539.
42. Naslund E., Barkeling B., King N., Gutniak M., Blundell J.E., Holst J.J., et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 1999, 23:304-311.
43. Turton M.D., O'Shea D., Gunn I., Beak S.A., Edwards C.M., Meeran K., et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 1996, 379:69-72.
44. Kieffer T.J., McIntosh C.H., Pederson R.A. Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 1995, 136:3585-3596.
45. Deacon C.F. Circulation and degradation of GIP and GLP-1. Horm Metab Res 2004, 36:761-765.
46. Hansen L., Deacon C.F., Orskov C., Holst J.J. Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine. Endocrinology 1999, 140:5356-5363.
47. Nauck M.A., Heimesaat M.M., Orskov C., Holst J.J., Ebert R., Creutzfeldt W. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993, 91:301-307.
48. Vaag A.A., Holst J.J., Volund A., Beck-Nielsen H.B. Gut incretin hormones in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM)-evidence for decreased glucagon-like peptide 1 secretion during oral glucose ingestion in NIDDM twins. Eur J Endocrinol 1996, 135:425-432.
49. Vilsboll T., Krarup T., Deacon C.F., Madsbad S., Holst J.J. Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 2001, 50:609-613.
50. Deacon C.F., Nauck M.A., Meier J., Hucking K., Holst J.J. Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide. J Clin Endocrinol Metab 2000, 85:3575-3581.
51. Nakanome C., Akai H., Umezu M., Toyota T., Goto Y. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus. Tohoku J Exp Med 1983, 139:287-292.
52. Eng J., Kleinman W.A., Singh L., Singh G., Raufman J.P. Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 1992, 267:7402-7405.
53. Bollman J.L., Cain J.C., Grindlay J.H. Techniques for the collection of lymph from the liver, small intestine, or thoracic duct of the rat. J Lab Clin Med 1948, 33:1349-1352.
54. Porter C.J., Charman WN Model systems for intestinal lymphatic transport studies. Models for assessing drug absorption and metabolism 1996, 85-102. Plenum Press, New York. R.T. Borchardt, P.L. Smith, G. Wilson (Eds.).
55. Dahan A., Mendelman A., Amsili S., Ezov N., Hoffman A. The effect of general anesthesia on the intestinal lymphatic transport of lipophilic drugs: comparison between anesthetized and freely moving conscious rat models. Eur J Pharm Sci 2007, 32:367-374.
56. Edwards G.A., Porter C.J., Caliph S.M., Khoo S.M., Charman W.N. Animal models for the study of intestinal lymphatic drug transport. Adv Drug Deliv Rev 2001, 50:45-60.
57. Polderman H., McCarrell J.D., Beecher H.K. Effect of anesthesia on lymph flow (local procaine, ether, pentobarbital sodium). Anesthesiology 1944, 5:400-406.
58. Tso P., Simmonds W.J. The absorption of lipid and lipoprotein synthesis. Lipid research methodology 1984, 191-216. Alan R. Liss Inc, New York. J.A. Story (Ed.).
59. Hayashi H., Fujimoto K., Cardelli J.A., Nutting D.F., Bergstedt S., Tso P. Fat feeding increases size, but not number, of chylomicrons produced by small intestine. Am J Physiol 1990, 259:G709-G719.
60. Lo C.M., Nordskog B.K., Nauli A.M., Zheng S., Vonlehmden S.B., Yang Q., et al. Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation?. Am J Physiol Gastrointest Liver Physiol 2008, 294:G344-G352.
61. Yoder S.M., Yang Q., Kindel T.L., Tso P. Differential responses of the incretin hormones GIP and GLP-1 to increasing doses of dietary carbohydrate but not dietary protein in lean rats. Am J Physiol Gastrointest Liver Physiol 2010, 299:G476-G485.
62. Kohan A.B., Qing Y., Cyphert H.A., Tso P., Salati L.M. Chylomicron remnants and nonesterified fatty acids differ in their ability to inhibit genes involved in lipogenesis in rats. J Nutr 2011, 141:171-176.
63. Yang L., Li X., Ji Y., Kohan A.B., Wang D.Q., Howles P.N., et al. Effect of ezetimibe on incretin secretion in response to the intestinal absorption of a mixed meal. Am J Physiol Gastrointest Liver Physiol 2010, 299:G1003-G1011.
64. Battle M.A., Bondow B.J., Iverson M.A., Adams S.J., Jandacek R.J., Tso P., et al. GATA4 is essential for jejunal function in mice. Gastroenterology 2008, 135:1676-1686. e1.
65. Jandacek R.J., Rider T., Yang Q., Woollett L.A., Tso P. Lymphatic and portal vein absorption of organochlorine compounds in rats. Am J Physiol Gastrointest Liver Physiol 2009, 296:G226-G234.
66. Hayashi H., Nutting D.F., Fujimoto K., Cardelli J.A., Black D., Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res 1990, 31:1613-1625.
67. Tso P., Balint J.A., Bishop M.B., Rodgers J.B. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am J Physiol 1981, 241:G487-G497.
68. Tso P., Buch K.L., Balint J.A., Rodgers J.B. Maximal lymphatic triglyceride transport rate from the rat small intestine. Am J Physiol 1982, 242:G408-G415.
69. Tso P., Gollamudi S.R. Pluronic L-81: a potent inhibitor of the transport of intestinal chylomicrons. Am J Physiol 1984, 247:G32-G36.
70. Hirano K., Young S.G., Farese R.V., Ng J., Sande E., Warburton C., et al. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J Biol Chem 1996, 271:9887-9890.
71. D'Alessio D., Lu W., Sun W., Zheng S., Yang Q., Seeley R., et al. Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system. Am J Physiol Regul Integr Comp Physiol 2007, 293:R2163-R2169.
72. Mentlein R., Gallwitz B., Schmidt W.E. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur J Biochem 1993, 214:829-835.
73. Barrowman J.A. Physiology of the gastro-intestinal lymphatic system 1978, Cambridge University Press, Cambridge Eng.; New York.
74. Yang Y.J., Hope I.D., Ader M., Bergman R.N. Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 1989, 84:1620-1628.
75. Lu W.J., Yang Q., Sun W., Woods S.C., D'Alessio D., Tso P. The regulation of the lymphatic secretion of glucagon-like peptide-1 (GLP-1) by intestinal absorption of fat and carbohydrate. Am J Physiol Gastrointest Liver Physiol 2007, 293:G963-G971.
76. Lewin K.J., Ulich T., Yang K., Layfield L. The endocrine cells of the gastrointestinal tract. Tumors II Pathol Annu 1986, 21(Pt 2):181-215.
77. Sjolund K., Sanden G., Hakanson R., Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983, 85:1120-1130.
78. Lu W.J., Yang Q., Sun W., Woods S.C., D'Alessio D., Tso P. Using the lymph fistula rat model to study the potentiation of GIP secretion by the ingestion of fat and glucose. Am J Physiol Gastrointest Liver Physiol 2008, 294:G1130-G1138.
79. Yoder S.M., Yang Q., Kindel T.L., Tso P. Stimulation of incretin secretion by dietary lipid: is it dose dependent?. Am J Physiol Gastrointest Liver Physiol 2009, 297:G299-G305.
80. Theodorakis M.J., Carlson O., Michopoulos S., Doyle M.E., Juhaszova M., Petraki K., et al. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 2006, 290:E550-E559.
81. Mortensen K., Petersen L.L., Orskov C. Colocalization of GLP-1 and GIP in human and porcine intestine. Ann NY Acad Sci 2000, 921:469-472.
82. Mortensen K., Christensen L.L., Holst J.J., Orskov C. GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 2003, 114:189-196.
83. Rocca A.S., Brubaker P.L. Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion. Endocrinology 1999, 140:1687-1694.
84. Roberge J.N., Brubaker P.L. Regulation of intestinal proglucagon-derived peptide secretion by glucose-dependent insulinotropic peptide in a novel enteroendocrine loop. Endocrinology 1993, 133:233-240.
85. Anini Y., Brubaker P.L. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 2003, 52:252-259.
86. Katsuma S., Hirasawa A., Tsujimoto G. Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 2005, 329:386-390.
87. Thomas C., Gioiello A., Noriega L., Strehle A., Oury J., Rizzo G., et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab 2009, 10:167-177.
88. Tong J., Tschop M.H., Aulinger B.A., Davis H.W., Yang Q., Liu J., et al. The intestinal lymph fistula model-a novel approach to study ghrelin secretion. Am J Physiol Gastrointest Liver Physiol 2010, 298:G474-G480.
89. Sabesin S.M., Frase S. Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine. J Lipid Res 1977, 18:496-511.
90. Tso P., Balint J.A. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol 1986, 250:G715-G726.
91. Nagatsu T., Hino M., Fuyamada H., Hayakawa T., Sakakibara S. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal Biochem 1976, 74:466-476.